Femasys announces CEO and Founder Kathy Lee-Sepsick met with the White House’s Gender Policy Council staff to discuss the Company’s reproductive health products and the future of women’s health in the United States. According to The White House, “The GPC covers a range of issues including economic security, health, gender-based violence and education, with a focus on gender equity and equality, and particular attention to the barriers faced by women and girls.” As part of the discussion, Ms. Lee-Sepsick and the GPC staff discussed the crucial need to fund women’s healthcare initiatives. The meeting was held in support of the President’s Executive Order on Advancing Women’s Health Research and Innovation, released in March 2024, which states, “The Director of OMB and the Assistant to the President and Director of the Gender Policy Council shall lead an effort, in collaboration with the Initiative, to identify current gaps in Federal funding for women’s health research and shall submit recommendations to the President describing the additional funding and programming necessary to catalyze research on women’s health, including in priority areas within women’s health as identified by the Initiative.”
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FEMY:
- Femasys CEO and Founder Kathy Lee-Sepsick Meets with the White House’s Gender Policy Council
- Femasys price target raised to $13 from $12 at H.C. Wainwright
- Femasys Announces Financial Results for Quarter Ended March 31, 2024 and Provides Corporate Update
- Femasys sees cash runway into 2H25
- Femasys reports Q1 EPS (17c), consensus (19c)